IRCT138902113843N1
Completed
未知
Evaluation of Typical Antipsychotic Augmentation with citalopram in reduction of Negative Symptoms in Inpatient schizophrenia in Ahvaz Golestan Hospital 1389
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Schizophrenia disorder.
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of schizophrenia based on DSM\-IV TR structured clinical interview by a psychiatrist (faculty member and psychiatry resident), prominent negative Symptoms (PANSS negative score more than 15\) , total PANSS score more than 50, no liver disease, no treatment with ECT within 6 months, age between 18 and 70, illness duration at least 1 year.
- •Exclusion criteria: depressive disorder based on DSM\-IV TR interview and more than 17 score by Hamilton depression rating scale , MR, schizoaffective, Bipolar disorder, Neurological disorders , severe organic disease for example IHD or CHF, treatment with anti depressants or lithium, deaf mute, substance abuse within 1 month ago (except nicotine and caffeine), use of any other drugs which had interactions with this study, active suicidal or homicidal thoughts, breast feeding or pregnancy, past history of allergy or complications with study medication, EPS, at least 3 months interval with the last dose of long term antipsychotic medication
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The Effect of Sertraline In Treatment Of SchizophreniaIRCT2014041317246N1Vice Chancellor for Research and Technology Development-Ahwaz Jondishapur University of Medical Sci30
Recruiting
Phase 2
Evaluation the effect of atypical antipsychotic augmentation with AtomoxetineSchizophrenia.SchizophreniaIRCT20100520003979N9Ahvaz University of Medical Sciences60
Recruiting
Not Applicable
The effects of antipsychotic maintenance therapy on brain volume: randomized (dis)continuation after remission of a first psychotic episode.Psychotic disorder / Schizophrenia10039628NL-OMON52454niversitair Medisch Centrum Groningen225
Completed
Not Applicable
Efficacy of treatment with antipsychotics in patients with psychotic disorder. The value of amino acid profile and neurotrophic proteins.psychosisschizophrenia10039628NL-OMON31735GGZ Groep Noord en Midden-Limburg100
Active, not recruiting
Not Applicable
Effectiveness of newer antipsychotic drugs compared to conventional antipsychotic drugs in patients with schizophreniaSchizophreniaMedDRA version: 14.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2009-010966-47-DEniversität Bremen